Summary
The incidence of tuberculosis in the developed countries has recently started to rise again due to increased migration, a higher rate of direct transmission ofMycobacterium tuberculosis, and co-infection with HIV. The impact of the latter on the pathogenesis and presentation of tuberculosis is summarised. Important measures to prevent the further spread of tuberculosis include rapid diagnosis, prompt isolation of infectious patients, adequate control of treatment compliance, as well as surveillance of local resistance patterns. Disease due to theMycobacterium avium complex is more frequent among HIV-infected patients in Central Europe than tuberculosis, and its development in the presence of immune deficiency seems to be mainly the result of a new infection with this ubiquitous microorganism rather than the reactivation of a previously acquired infection. It has a significant impact on mortality. The diagnosis ofMycobacterium avium complex infection requires a high degree of conjecture because most of the symptoms are non-specific, such as fever, night sweats, weight loss and anaemia. Promptly initiated treatment significantly prolongs the survival time of those affected by comparison with untreated patients.
Similar content being viewed by others
References
Ledergerber, B., von Overbeck, J., Egger, M., Lüthy, R., the Swiss HIV Cohort Study (SHCS) The Swiss HIV cohort study: rationale, organization and selected baseline characteristics. Soz. Präventivmed. 39 (1994) 387–394.
Raviglione, M. C., Sudre, P., Rieder, H. L., Spinaci, S., Kochi, A. Secular trends of tuberculosis in western Europe. Bull. World Health Organ. 71 (1993) 297–306.
Sudre, P., ten Dam, G., Kochi, A. Tuberculosis: a global overview of the situation today. Bull. World Health Organ. 70 (1992) 149–159.
Rieder, H. L., Cauthen, G. M., Bloch, A. B., Cole, C. H., Holtzman, D., Snider, D. E., Jr., Bigler, W. J., Witte, J. J. Tuberculosis and acquired immunodeficiency syndrome — Florida. Arch. Intern. Med. 149 (1989) 1268–1273.
Centers for Disease Control Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 41 (1992) 61–71.
Barnes, P. F., Bloch, A. B., Davidson, P. T., Snider, D. E., Jr. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324 (1991) 1644–1650.
Genewein, A., Telenti, A., Bernasconi, C., Mordasini, C., Weiss, S., Maurer, A. M., Rieder, H. L., Schopfer, K., Bodmer, T. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 342 (1993) 841–844.
Peloquin, C. A., MacPhee, A. A., Berning, S. E. Malabsorption of antimycobacterial medications. N. Engl. J. Med. 329 (1993) 1122–1123.
Bloch, A. B., Cauthen, G. M., Onorato, I. M., Dansbury, K. G., Kelly, G. D., Driver, C. R., Snider, D. E., Jr. Nationwide survey of drugresistant tuberculosis in the United States. JAMA 271 (1994) 665–671.
Raviglione, M. C., Snider, D. E., Jr., Kochi, A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273 (1995) 220–226.
Pfyffer, G. E. Tuberkulose: Diagnostik und Resistenzhäufigkeit 1991/92. Schweiz. Rundsch. Med. (Prax.) 82 (1993) 1090–1094.
Brudney, K., Dobkin, J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am. Rev. Respir. Dis. 144 (1991) 745–749.
Horsburgh, C. R., Jr., Selik, R. M. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis. 139 (1989) 4–7.
Raszka, W. V., Jr., Skillman, L. P., McEvoy, P. L., Robb, M. L. Isolation of nontuberculous, non-avium mycobacteria from patients infected with human immunodeficiency virus. Clin. Infect. Dis. 20 (1995) 73–76.
Jenkins, S., Hillman, R., Barnes, N., Goh, B.: Mycobacterial disease in HIV positive patients in east London. Fourth European Conference on Clinical Aspects and Treatment of HIV Infection, Milan, Italy. (1994) abstract P347.
Opravil, M., Pechère, M., Lazzarin, A., Heald, A., Rüttimann, S., Iten, A., Furrer, H., Oertle, D., Praz, G., Vuitton, D. A., Hirschel, B., Lüthy, R. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus. Clin. Infect. Dis. 20 (1995) 244–249.
von Reyn, C. F., Barber, T. W., Arbeit, R. D., Sox, C. H., O'Connor, G. T., Brindle, R. J., Gilks, C. F., Hakkarainen, K., Ranki, A., Bartholomew, C., Edwards, J., Tosteson, A. N. A., Magnusson, M. Evidence of previous infection withMycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J. Infect. Dis. 168 (1993) 1553–1558.
Wayne, L. G., Young, L. S., Bertram, M. Absence of mycobacterial antibody in patients with acquired immune deficiency syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 5 (1986) 363–365.
von Reyn, C. F., Maslow, J. N., Barber, T. W., Falkinham, J. O., 3 rd, Arbeit, R. D. Persistent colonisation of potable water as a source ofMycobacterium avium infection in AIDS. Lancet 343 (1994) 1137–1141.
Yajko, D. M., Chin, D. P., Gonzalez, P. C., Nassos, P. S., Hopewell, P. C., Reingold, A. L., Horsburgh, C. R., Jr., Yakrus, M. A., Ostroff, S. M., Hadley, W. K. Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9 (1995) 176–182.
Chin, D. P., Hopewell, P. C., Yajko, D. M., Vittinghoff, E., Horsburgh, C. R., Jr., Hadley, W. K., Stone, E. N., Nassos, P. S., Ostroff, S. M., Jacobson, M. A., Matkin, C. C., Reingold, A. L. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk ofM. avium complex bacteremia in patients with human immunodeficiency virus infection. J. Infect. Dis. 169 (1994) 289–295.
Havlik, J. A., Jr., Metchock, B., Thompson, S. E., Barrett, K., Rimland, D., Horsburgh, C. R., Jr. A prospective evaluation ofMycobacterium avium complex colonization of the respiratory and gastrointestinal tracts of persons with human immunodeficiency virus infection. J. Infect. Dis. 168 (1993) 1045–1048.
Kemper, C. A., Havlir, D., Bartok, A. E., Kane, C., Camp, B., Lane, N., Deresinski, S. C. Transient bacteremia due toMycobacterium avium complex in patients with AIDS. J. Infect. Dis. 170 (1994) 488–493.
Torriani, F. J., McCutchan, J. A., Bozzette, S. A., Grafe, M. R., Havlir, D. V. Autopsy findings in AIDS patients withMycobacterium avium complex bacteremia. J. Infect. Dis. 170 (1994) 1601–1605.
Chin, D. P., Reingold, A. L., Stone, E. N., Vittinghoff, E., Horsburgh, C. R., Jr., Simon, E. M., Yajko, D. M., Hadley, W. K., Ostroff, S. M., Hopewell, P. C. The impact ofMycobacterium avium complex bacteremia and its treatment on survival of AIDS patients — a prospective study. J. Infect. Dis. 170 (1994) 578–584.
Nightingale, S. D., Byrd, L. T., Southern, P. M., Jockusch, J. D., Cal, S. X., Wynne, B. A. Incidence ofMycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J. Infect. Dis. 165 (1992) 1082–1085.
Gordin, F., Cohn, D., Sullam, P., Schoenfelder, J., Wynne, B., Horsburgh, C. R., Jr., the Rifabutin Study Group: The occurrence ofMycobacterium avium complex bacteremia in a standardized cohort of AIDS patients. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, USA. (1993) abstract 1405.
Opravil, M., Hächler, I., Lüthy, R. Incidence and prophylaxis of non-tuberculous mycobacteriosis in HIV-infected patients. AIDS 8 (1994) 563–564.
d'Arminio Monforte, A., Vago, L., Lazzarin, A., Boldorini, R., Bini, T., Guzzetti, S., Antinori, S., Moroni, M., Costanzi, G. AIDS-defining diseases in 250 HIV-infected patients: a comparative study of clinical and autopsy diagnoses. AIDS 6 (1992) 1159–1164.
Hoover, D. R., Saah, A. J., Bacellar, H., Phair, J., Detels, R., Anderson, R., Kaslow, R. A., for the Multicenter AIDS Cohort Study Clinical manifestations of AIDS in the era ofPneumocystis prophylaxis. N. Engl. J. Med. 329 (1993) 1922–1926.
Benson, C. A. Disease due to theMycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin. Infect. Dis. 18 Suppl. 3 (1994) S218-S222.
Pechère, C., Opravil, M., Wald, A., Chave, J. P., Bessesen, M., Sievers, A., Hein, R., von Overbeck, J., Clark, R. A., Tortoli, E., Emler, S., Kirschner, P., Gabriel, V., Böttger, E. C., Hirschel, B., the Swiss HIV Cohort Study Clinical and epidemiologic features of infection withMycobacterium genavense. Arch. Intern. Med. 155 (1995) 400–404.
Straus, W. L., Ostroff, S. M., Jernigan, D. B., Kiehn, T. E., Sordillo, E. M., Armstrong, D., Boone, N., Schneider, N., Kilburn, J. O., Silcox, V. A., LaBombardi, V., Good, R. C. Clinical and epidemiologic characteristics ofMycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Arch. Intern. Med. 120 (1994) 118–125.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Opravil, M. Epidemiological and clinical aspects of mycobacterial infections. Infection 25, 56–59 (1997). https://doi.org/10.1007/BF02113516
Issue Date:
DOI: https://doi.org/10.1007/BF02113516